Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Janssen-Cilag S.p.A.
Age
18–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant must meet Diagnostic and Statistical Manual of Mental Disorders (5th edition) (DSM-5) diagnostic criteria for single episode or recurrent Major Depressive Disorder (MDD), based upon clinical assessment
In the physician's opinion the current depressive episode is moderate-to-severe in terms of severity.
In the physician's opinion, acute psychiatric hospitalization is clinically warranted due to participant's current active suicidal ideation with intent
Participant must be capable of discernment
Participant must be able to read and write in the Italian language
Participant must have signed the informed consent form (ICF) indicating that he/she understands the study purpose and is willing to participate in the study
Participant is in the site's catchment area, as evaluated by the Investigator
You may not be if
Participant currently (that is, at the time of enrolment and based upon clinical assessment) meets DSM-5 criteria for psychotic disorder, bipolar or related disorders, antisocial personality disorder, borderline personality disorder, intellectual disability, autism spectrum disorder, dementia
Participant meets the DSM-5 severity criteria for moderate or severe substance or alcohol use disorder (except for nicotine or caffeine) within the 6 months before enrolment, based upon clinical assessment
Participant has participated in or is currently enrolled in any clinical trial with experimental treatments within the current major depressive episode
Clareo Health | A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in Italy
